Skip to main content

Table 1 Definition of quality indicators for surgical care of breast cancer

From: Factors analysis on the use of key quality indicators for narrowing the gap of quality of care of breast cancer

TitleQuality indicators
Process
 1Breast cancer patients who received mammography or breast ultrasound before surgery
 2Breast cancer patients who had diagnosis in cytology and/or histology before surgery
 3Breast cancer patients who received ER and PR assessment before systemic therapy
 4HER2 assessment before systemic therapy
 5Stage I-II breast cancer patients who underwent breast-conserving surgery
 6Breast cancer patients who received sentinel lymph nodes biopsy
 7Breast cancer patients who received axillary lymph nodes dissection
 8Premenopausal breast cancer patients who were administrated adjuvant chemotherapy
 9Postmenopausal breast cancer patients with high risk who received Adjuvant chemotherapy
 10Breast cancer patients who were administrated at least four cycles of Adjuvant chemotherapy
 11Breast cancer patients treated by trastuzumab in whom heart function was monitored every 3 months
 12Breast cancer patient whose radiotherapy treatment was completed within a 7-week interval from the initiation of radiotherapy after breast-conserving surgery
 13Breast cancer patients who received standard dose of radiotherapy at the whole breast after breast-conserving surgery
 14Breast cancer patients who received adjuvant radiotherapy at chest wall
 15Breast cancer patients who received tamoxifen or aromatase inhibitor treatment
 16Breast cancer patients who received neo-adjuvant chemotherapy
 17Breast cancer patients with hormone receptor status of the tumor stated in Pathology report
 18Breast cancer patients with pathology report stated category of primary tumor and regional lymph nodes with histologic grade
 19Breast cancer patients with pathology report stated number of Examined lymph nodes and positive nodes
 20Breast cancer patients with hormone receptor status of the tumor Stated in pathology report
 21Breast cancer patients with tumor size documented in pathology report
Management of symptoms or treatment toxicity
 22Breast cancer patients who were administrated potent anti-emetic therapy
Communication and Cooperation
 23Breast cancer patients who were recommended for five-year endocrine treatment